SPRO earnings: a negative outcome, -18.7%

On March 16, 2020, Spero Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -18.7% in the window around the event. It had already run -27.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.